Anaplastic thyroid cancer : Pathogenesis, prognostic factors and genetic landscape (Review)
Copyright: © Alhejaily et al..
Anaplastic thyroid cancer (ATC) is a rare and aggressive form of thyroid malignancy, presenting significant challenges in diagnosis and treatment. The rarity of this cancer and its aggressive nature make an accurate diagnosis difficult, requiring a multidisciplinary approach and various imaging techniques. Treatment involves a personalized multimodal approach, including surgery, adjuvant therapies and risk stratification. Prognostic factors such as age, tumor characteristics and genetic alterations play a crucial role in determining patient outcomes. Despite advancements, gaps remain in understanding the underlying mechanisms of the disease and establishing standardized treatment guidelines. Further research, collaborative efforts and multicenter studies are necessary to improve diagnostic accuracy, develop targeted therapies and biomarkers, and enhance the long-term management. The present review provides a comprehensive overview of ATC, discussing its clinical manifestations, diagnostic approaches, treatment options, prognostic factors and genetic landscape.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Molecular and clinical oncology - 19(2023), 6 vom: 21. Dez., Seite 99 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Alhejaily, Abdul-Mohsen G [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anaplastic thyroid cancer |
|---|
| Anmerkungen: |
Date Revised 01.12.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3892/mco.2023.2695 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365139912 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365139912 | ||
| 003 | DE-627 | ||
| 005 | 20231226101035.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3892/mco.2023.2695 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1217.xml |
| 035 | |a (DE-627)NLM365139912 | ||
| 035 | |a (NLM)38022847 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Alhejaily, Abdul-Mohsen G |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Anaplastic thyroid cancer |b Pathogenesis, prognostic factors and genetic landscape (Review) |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.12.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright: © Alhejaily et al. | ||
| 520 | |a Anaplastic thyroid cancer (ATC) is a rare and aggressive form of thyroid malignancy, presenting significant challenges in diagnosis and treatment. The rarity of this cancer and its aggressive nature make an accurate diagnosis difficult, requiring a multidisciplinary approach and various imaging techniques. Treatment involves a personalized multimodal approach, including surgery, adjuvant therapies and risk stratification. Prognostic factors such as age, tumor characteristics and genetic alterations play a crucial role in determining patient outcomes. Despite advancements, gaps remain in understanding the underlying mechanisms of the disease and establishing standardized treatment guidelines. Further research, collaborative efforts and multicenter studies are necessary to improve diagnostic accuracy, develop targeted therapies and biomarkers, and enhance the long-term management. The present review provides a comprehensive overview of ATC, discussing its clinical manifestations, diagnostic approaches, treatment options, prognostic factors and genetic landscape | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a BRAF | |
| 650 | 4 | |a anaplastic thyroid cancer | |
| 650 | 4 | |a molecular pathogenesis | |
| 650 | 4 | |a prognosis | |
| 650 | 4 | |a thyroid malignancy | |
| 700 | 1 | |a Alhuzim, Omar |e verfasserin |4 aut | |
| 700 | 1 | |a Alwelaie, Yazeed |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular and clinical oncology |d 2013 |g 19(2023), 6 vom: 21. Dez., Seite 99 |w (DE-627)NLM236574981 |x 2049-9469 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2023 |g number:6 |g day:21 |g month:12 |g pages:99 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3892/mco.2023.2695 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2023 |e 6 |b 21 |c 12 |h 99 | ||